CJC-1295 No DAC
10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.
$139.99
DetailsHover to zoom
Growth Hormone ResearchSynthetic research compound
Tesamorelin / Ipamorelin
$119.99
6/3 mg· 2 strengths availableThis preparation combines tesamorelin, a stabilized GHRH analog, with ipamorelin, a selective agonist at the growth hormone secretagogue receptor (ghrelin receptor).
The two compounds act on separate receptors that converge on the same pituitary cell population, so the blend is used in laboratory research examining how parallel inputs to the somatotroph axis interact.
Research areas
GHRH receptor signalingGhrelin receptor activitySomatotroph pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic research compound
- Research category
- Growth Hormone Research
- SKU
- NVR-TESAMORELIN-IPAMORELIN-6-3MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Select strength
Cost per mg shown for each option
1
$119.99per 6/3 mg$13.33/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on Tesamorelin / Ipamorelin.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
Growth-hormone regulation in preclinical models involves at least two distinct receptor inputs: GHRH receptor activation and growth hormone secretagogue receptor activation. Supplying both agonists in a fixed preparation lets investigators study convergent signaling without preparing two materials for each condition. As with any blend, single-agonist controls are needed to attribute a response to one receptor. This material is a research reagent; no claims are made about physiological outcomes.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
Tesamorelin / Ipamorelin is studied within its research category (Growth Hormone Research) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
GHRH receptor signalingGhrelin receptor activitySomatotroph pathway researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
Tesamorelin / Ipamorelin is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related
View all →Related research materials
CJC-1295 No DAC / Ipamorelin
5/5 mg
Combined GHRH analog and secretagogue receptor agonist preparation for dual-input pituitary research.
$59.99
DetailsCJC-1295 w/DAC
5 mg
GHRH analog with Drug Affinity Complex modification for extended-duration receptor research.
$79.99
DetailsGHRP-2 Acetate
10 mg
Second-generation growth hormone releasing peptide studied as a ghrelin receptor agonist reference.
$39.99
DetailsTesamorelin / Ipamorelin
6/3 mg · $119.99